← Open Payments lookup

AYME FROMETA: Open Payments

NPI 1669600995 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$927 in 64 payments from 9 companies in 2025. Trend: 2023 $389 · 2024 $813 · 2025 $927

Food & beverage: $927
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.19$290
ABBVIE INC.22$236
Takeda Pharmaceuticals U.S.A., Inc.6$102
Teva Pharmaceuticals USA, Inc.5$94
E.R. Squibb & Sons, L.L.C.5$86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$52
Axsome Therapeutics, Inc.2$35
Lundbeck LLC1$17
Vanda Pharmaceuticals Inc.1$16

Products named: REXULTI, VRAYLAR, TRINTELLIX, UZEDY, COBENFY, CAPLYTA, ABILIFY ASIMTUFII, Auvelity.

Industry payments across NJ — which companies pay providers there.